AJMC - The American Journal of Managed Care?featured TiNivo-2 study author Katy?Beckermann, MD, PhD, discussing data from an exploratory analysis evaluating patient reported outcomes (PROs) among those treated with tivozanib monotherapy and those given combination tivozanib and nivolumab for advanced renal cell carcinoma. These data were presented at the recent?American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium (ASCO GU). View the video here:?https://lnkd.in/eMTfxsv2 ? #tinivo2 #tivozanib #ASCOGU2025 #GU25 #genitourinary #oncology #biotech #pharma #cancer #RCC #renalcellcarcinoma #clinicaltrials #PatientReportedOutcomes
AVEO Oncology
生物技术研究
Boston,Massachusetts 22,651 位关注者
Committed to delivering medicines that provide a better life for patients with cancer.
关于我们
AVEO is a commercial-stage, oncology-focused biopharmaceutical company committed to delivering medicines that provide a better life for patients with cancer. AVEO currently markets FOTIVDA? (tivozanib) in the U.S. for the treatment of adult patients with relapsed or refractory renal cell carcinoma (RCC) following two or more prior systemic therapies. AVEO continues to develop FOTIVDA in immuno-oncology combinations in RCC and other indications, and has other investigational programs in clinical development. AVEO is committed to creating an environment of diversity, equity and inclusion to diversify representation within the Company.
- 网站
-
https://www.aveooncology.com
AVEO Oncology的外部链接
- 所属行业
- 生物技术研究
- 规模
- 51-200 人
- 总部
- Boston,Massachusetts
- 类型
- 上市公司
- 创立
- 2001
- 领域
- Oncology
地点
-
主要
30 Winter St
3rd Floor
US,Massachusetts,Boston,02108
AVEO Oncology员工
-
Deb Wall
PEOPLE | CULTURE | LEADERSHIP | DEVELOPMENT | ENGAGEMENT | OPERATIONAL EXCELLENCE
-
Ken Kirsch
Market Insights Leader Driving Bottom Line Results via the intersection of Market Research, Analytics, Portfolio Planning and Competitive…
-
Arlyssa LaPorte
-
Samuel Villa
AVEO Oncology an LG Chem company
动态
-
Michael Bailey, President and CEO of AVEO Oncology, an LG Chem company, joined host Alberto Grignolo on a recent episode of the Parexel #ClinicalTrialblazers podcast. In the episode, Mr. Bailey covers leadership skills, navigating challenges one day at a time, and the importance of serving patients, which have all contributed to a successful career pioneering oncology clinical trials. You can listen to the full conversation and key insights here: https://lnkd.in/eHG5E6NP #clinicaltrials #oncology #leadership #pharma
-
Happy 4th?anniversary, FOTIVDA? (tivozanib)! On March 10, 2021, FOTIVDA received?U.S.?FDA?approval. Four years later,?AVEO Oncology, an?LG Chem?company, commemorates this important milestone as we continue our commitment?to provide innovative solutions to improve the lives of people affected by cancer. #biotech?#pharma?#cancer?#tivozanib
-
-
March is?#KidneyCancerAwarenessMonth?and?AVEO Oncology, an?LG Chem?company, encourages everyone to #OrangeUp?in support of patients and their families affected by?#kidneycancer.?This month aims to raise awareness about kidney cancer, its symptoms, risk factors, and treatment options. It also encourages early detection, research, and support for those affected by this disease. AVEO joins our advocacy group partners in their efforts to support the kidney cancer community in March and all year long! #oncology?#pharma?#cancer
-
-
Join?AVEO Oncology, an?LG Chem?company, today on?#RareDiseaseDay?as we recognize the ~300M people worldwide affected by rare diseases. To learn more about raising awareness as well as?access to diagnosis and therapies for people living with a rare?disease, please visit?rarediseaseday.org. #raredisease?#rarediseaseawareness
-
-
DISCOVER OUR ENHANCED WEBSITE! We’re excited to reveal our newly updated website with enhanced visual elements, improved navigation, and all the latest information and news about?AVEO Oncology, an?LG Chem?company, to optimize user experience. Explore now at:?www.aveooncology.com ? #oncology #pharma #biotech #aveooncology #newwebsite
-
-
AVEO Oncology, an?LG Chem?company, presented two abstracts at the?American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium. Both abstracts present exploratory analysis data for tivozanib from studies involving patients with advanced RCC. For full details, read our press release here?https://lnkd.in/eMXNEfph?? ? #ASCOGU2025?#GU25?#genitourinary?#oncology?#biotech?#pharma?#cancer?#clinicaltrials #tivozanib
-
AVEO Oncology, an LG Chem company, will present two abstracts at the upcoming American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium February 13-15, 2025. For full presentation details, read our press release here https://lnkd.in/etXt4d2y. If you are attending #ASCOGU, please visit us at booth #63. #ASCOGU2025 #GU25 #genitourinary #oncology #biotech #pharma #cancer
-
Today, on?#WorldCancerDay,?AVEO Oncology, an?LG Chem?company, joins?Union for International Cancer Control (UICC)?and its efforts to improve global cancer education, including this year’s “United by Unique” campaign, a people-centered approach to making a difference in the cancer community.? ? #closethegap #UICC #cancereducation #oncology #pharma
-
-
Everyone - regardless of race - deserves equal access to cancer care, treatment, and preventative education.?That’s why we are dedicated to our mission at?AVEO Oncology, an?LG Chem?company, of reducing cancer care disparities that disproportionately impact African-Americans by providing innovative solutions to improve cancer patients' lives. ? #blackhistorymonth
-